Ani Pharmaceuticals (ANIP) Net Equity Issued and Repurchased (2010 - 2012)

Ani Pharmaceuticals (ANIP) has 3 years of Net Equity Issued and Repurchased data on file, last reported at -$7933.0 in Q4 2012.

• For the quarter ending Q4 2012, Net Equity Issued and Repurchased changed N/A year-over-year to -$7933.0; the trailing twelve-month figure through Sep 2023 stood at -$7933.0 (down 183.66% YoY), and the FY2023 full-year result was $80.6 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased fell to -$7933.0 in Q4 2012, from $17415.0 in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $23.9 million in Q1 2011 to a low of -$41045.0 in Q2 2011.
• A 3-year average of $6.8 million and a median of $8575.5 in 2010 frame the typical range for Net Equity Issued and Repurchased.
• Peak annual rise in Net Equity Issued and Repurchased reached 6696.59% in 2011, while the deepest fall reached 6696.59% in 2011.
• Tracing ANIP's Net Equity Issued and Repurchased over 3 years: stood at $16.9 million in 2010, then sank by 99.9% to $17415.0 in 2011, then plunged by 145.55% to -$7933.0 in 2012.
• Business Quant data shows ANIP's Net Equity Issued and Repurchased at -$7933.0 in Q4 2012, $17415.0 in Q3 2011, and -$41045.0 in Q2 2011.